WHO ICTRP trial
Efficacy of switching ICS to salmeterol/fluticasone combination aerosol in…
JPRN-UMIN000020229 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000020229 |
|---|---|
| Public title | Efficacy of switching ICS to salmeterol/fluticasone combination aerosol in patients with adult bronchial asthma |
| Scientific title | Efficacy of switching ICS to salmeterol/fluticasone combination aerosol in patients with adult bronchial asthma - Efficacy of switching ICS to salmeterol/fluticasone combination aerosol in patients with adult bronchial asthma |
| Primary sponsor | Matsuyama-Red-Cross-Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | bronchial asthma |
| Interventions | The patients switched from their previous treatment with ICS to SFC, which contained the same amount of ICS. We evaluated the peak expiratory flow (PEF), ACT, and dose counter during a 12-week period. |
| Registration date | Dec 21, 2015 |
| Target size | 25 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: